BAY-1128688

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameBAY-1128688
Drug Alias NameBAY-1128688
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAldo-keto-reductase family 1 member C3 inhibitors
TargetsAldo-keto-reductase family 1 member C3
Therapy Area/IndicationsEndometriosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumPoland +[13] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBayer AG
Active IndicationsN/A
Inactive IndicationsEndometriosis

Other Information

ATC CodeN/A
Related LinksN/A